Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Pines

Showing results (31-40 of 54) with videos related to

Pageof 6
Sort By:
The Prostate|April 12, 2002
Growth inhibition of prostate cancer xenografts by halofuginoneZohar Gavish, Jehonathan H Pinthus, Vivian Barak, et al.
Biochimica Et Biophysica Acta|April 8, 2014
Halofuginone improves muscle-cell survival in muscular dystrophiesAnna Bodanovsky, Noga Guttman, Hila Barzilai-Tutsch, et al.
The Journal of Urology|September 9, 2005
Inhibition of Wilms tumor xenograft progression by halofuginone is accompanied by activation of WT-1 gene expressionJehonathan H Pinthus, Yuval Sheffer, Arnon Nagler, et al.
Histology and Histopathology|January 1, 2013
Inhibition of muscle fibrosis and improvement of muscle histopathology in dysferlin knock-out mice treated with halofuginoneOrna Halevy, Olga Genin, Hila Barzilai-Tutsch, et al.
The Laryngoscope|September 9, 2005
Prevention of esophageal strictures in a caustic burn model using halofuginone, an inhibitor of collagen type I synthesisDan Arbell, Raphael Udassin, Benjamin Z Koplewitz, et al.
Arthritis and Rheumatism|October 18, 2002
Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanismTracy L McGaha, Takao Kodera, Harry Spiera, et al.
Plos One|August 6, 2011
Th17 cells and IL-17 in protective immunity to vaginal candidiasisDonatella Pietrella, Anna Rachini, Mark Pines, et al.
Development (Cambridge, England)|July 24, 2002
The IIIc alternative of Fgfr2 is a positive regulator of bone formationVereragavan P Eswarakumar, Efrat Monsonego-Ornan, Mark Pines, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivoDavid J Gross, Israel Reibstein, Lola Weiss, et al.
The American Journal of Pathology|January 1, 2013
The involvement of collagen triple helix repeat containing 1 in muscular dystrophiesItai Spector, Yael Zilberstein, Adi Lavy, et al.
Pageof 6

Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
The Prostate|April 12, 2002
Growth inhibition of prostate cancer xenografts by halofuginoneZohar Gavish, Jehonathan H Pinthus, Vivian Barak, et al.
Biochimica Et Biophysica Acta|April 8, 2014
Halofuginone improves muscle-cell survival in muscular dystrophiesAnna Bodanovsky, Noga Guttman, Hila Barzilai-Tutsch, et al.
The Journal of Urology|September 9, 2005
Inhibition of Wilms tumor xenograft progression by halofuginone is accompanied by activation of WT-1 gene expressionJehonathan H Pinthus, Yuval Sheffer, Arnon Nagler, et al.
Histology and Histopathology|January 1, 2013
Inhibition of muscle fibrosis and improvement of muscle histopathology in dysferlin knock-out mice treated with halofuginoneOrna Halevy, Olga Genin, Hila Barzilai-Tutsch, et al.
The Laryngoscope|September 9, 2005
Prevention of esophageal strictures in a caustic burn model using halofuginone, an inhibitor of collagen type I synthesisDan Arbell, Raphael Udassin, Benjamin Z Koplewitz, et al.
Arthritis and Rheumatism|October 18, 2002
Halofuginone inhibition of COL1A2 promoter activity via a c-Jun-dependent mechanismTracy L McGaha, Takao Kodera, Harry Spiera, et al.
Plos One|August 6, 2011
Th17 cells and IL-17 in protective immunity to vaginal candidiasisDonatella Pietrella, Anna Rachini, Mark Pines, et al.
Development (Cambridge, England)|July 24, 2002
The IIIc alternative of Fgfr2 is a positive regulator of bone formationVereragavan P Eswarakumar, Efrat Monsonego-Ornan, Mark Pines, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Treatment with halofuginone results in marked growth inhibition of a von Hippel-Lindau pheochromocytoma in vivoDavid J Gross, Israel Reibstein, Lola Weiss, et al.
The American Journal of Pathology|January 1, 2013
The involvement of collagen triple helix repeat containing 1 in muscular dystrophiesItai Spector, Yael Zilberstein, Adi Lavy, et al.
Pageof 6